Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Controversy about pharmacological modulation of Nrf2 for cancer therapy
Lidija Milković, Neven Žarković, Luciano Saso
Redox Biology (2017) Vol. 12, pp. 727-732
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
Henry Jay Forman, Hongqiao Zhang
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 9, pp. 689-709
Open Access | Times Cited: 1884
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado, Gina Manda, Ahmed Hassan, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 348-383
Open Access | Times Cited: 537
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
Natalia Robledinos-Antón, Raquel Fernández-Ginés, Gina Manda, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-20
Open Access | Times Cited: 528
The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases
Wen‐Jun Tu, Hong Wang, Song Li, et al.
Aging and Disease (2018) Vol. 10, Iss. 3, pp. 637-637
Open Access | Times Cited: 527
Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts
Lidija Milković, Ana Čipak Gašparović, Marina Cindrić, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 793-793
Open Access | Times Cited: 278
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
Filipa Lopes‐Coelho, Filipa Martins, Sofia A. Pereira, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3765-3765
Open Access | Times Cited: 277
Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
Joanna Kopecka, Patrick Trouillas, Ana Čipak Gašparović, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100670-100670
Open Access | Times Cited: 217
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Manuel Matzinger, Katrin Fischhuber, Elke H. Heiß
Biotechnology Advances (2017) Vol. 36, Iss. 6, pp. 1738-1767
Open Access | Times Cited: 188
Protective effects of lycopene in cancer, cardiovascular, and neurodegenerative diseases: An update on epidemiological and mechanistic perspectives
Ramesh Kumar Saini, Kannan R. R. Rengasamy, Mohamad Fawzi Mahomoodally, et al.
Pharmacological Research (2020) Vol. 155, pp. 104730-104730
Closed Access | Times Cited: 144
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103
Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
Javad Sharifi‐Rad, Véronique Seidel, Michalak Izabela, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Nrf2 as regulator of innate immunity: A molecular Swiss army knife!
Maurizio Battino, Francesca Giampieri, Francesca Pistollato, et al.
Biotechnology Advances (2017) Vol. 36, Iss. 2, pp. 358-370
Closed Access | Times Cited: 154
Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis
Natalia Siwecka, Wioletta Rozpędek‐Kamińska, Dariusz Pytel, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4354-4354
Open Access | Times Cited: 132
Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?
Tharindu L. Suraweera, H.P. Vasantha Rupasinghe, Graham Dellaire, et al.
Antioxidants (2020) Vol. 9, Iss. 10, pp. 973-973
Open Access | Times Cited: 130
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Petra Jagušt, Beatriz de Luxán‐Delgado, Beatriz Parejo-Alonso, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 127
Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer
Luka Andrišić, Danuta Dudzik, Coral Barbas, et al.
Redox Biology (2017) Vol. 14, pp. 47-58
Open Access | Times Cited: 123
The NRF2, Thioredoxin, and Glutathione System in Tumorigenesis and Anticancer Therapies
Morana Jaganjac, Lidija Milković, Suzana Borović Šunjić, et al.
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1151-1151
Open Access | Times Cited: 114
Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion
Sander Bekeschus, Ramona Clemen, Felix Nießner, et al.
Advanced Science (2020) Vol. 7, Iss. 10
Open Access | Times Cited: 105
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
Matej Sova, Luciano Saso
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 3181-3197
Open Access | Times Cited: 90
Insight into novel β-cyclodextrin-grafted-poly (N-vinylcaprolactam) nanogel structures as advanced carriers for 5-fluorouracil: Equilibrium behavior and pharmacokinetic modeling
Hayam M. El-Zeiny, Mostafa R. Abukhadra, Ossama M. Sayed, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2019) Vol. 586, pp. 124197-124197
Closed Access | Times Cited: 90
The relevance of pathophysiological alterations in redox signaling of 4-hydroxynonenal for pharmacological therapies of major stress-associated diseases
Morana Jaganjac, Lidija Milković, Agnieszka Gęgotek, et al.
Free Radical Biology and Medicine (2019) Vol. 157, pp. 128-153
Open Access | Times Cited: 90
Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects
Bernardino Clavo, Francisco Rodríguez‐Esparragón, Delvys Rodríguez‐Abreu, et al.
Antioxidants (2019) Vol. 8, Iss. 12, pp. 588-588
Open Access | Times Cited: 88
Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis
Danica Michaličková, Tomáš Hrnčíř, Nikolina Kutinová Canová, et al.
European Journal of Pharmacology (2020) Vol. 873, pp. 172973-172973
Closed Access | Times Cited: 87
Glucose as a Major Antioxidant: When, What for and Why It Fails?
Andriy Cherkas, Serhii Holota, Tamaz Mdzinarashvili, et al.
Antioxidants (2020) Vol. 9, Iss. 2, pp. 140-140
Open Access | Times Cited: 84
Crosstalk between autophagy and metabolic regulation of cancer stem cells
Mouradi El Hout, Emma Cosialls, Maryam Mehrpour, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top